{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:52:23Z","timestamp":1793879543519,"version":"4.7.0"},"reference-count":41,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,11,13]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To provide comprehensive information on the burden of myasthenia gravis (MG) in Italy, including the unmet needs of patients and several other aspects related to the disease, based on skilled viewpoints of MG experts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Iterative analysis conducted in accordance with the best practices of the Delphi method, including anonymity, controlled feedback, and statistical stability of consensus.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting and participants<\/jats:title>\n                  <jats:p>24 clinicians, 18 public health experts and 4 patient associations experts completed all the Delphi iterations between 18 April and 3 July 2023, for a total of 46 participants from several Italian Regions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcome measures<\/jats:title>\n                  <jats:p>Five areas of investigation related to MG were examined: epidemiology in Italy and characteristics of disease; diagnostic issues and Italian patient journey; unmet needs during the acute and chronic phases of MG; quality of life; public health management of MG. Consensus in the Delphi iterations was defined by both the percentage level of agreement between panellists or the median value of the responses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We reported a high level of agreement (ie, &gt;66.7% of panellists) on the prevalence and incidence of disease in Italy and on several management issues. A strong impact of MG on the quality of life of patients also emerged. Cross-agreement was achieved among different subgroups of panellists (ie, clinicians, public health experts and patient associations representatives) for most items proposed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study provided guidance for educational and practical aspects of MG in Italy, highlighted disease severity and its role on patients\u2019 quality of life. A few gaps related to the handling of MG in Italy also emerged.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-086225","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T09:36:11Z","timestamp":1734860171000},"page":"e086225","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology, management and patient needs in myasthenia gravis: an Italian multistakeholder consensus based on Delphi methodology"],"prefix":"10.1136","volume":"14","author":[{"given":"Francesco","family":"Habetswallner","sequence":"first","affiliation":[{"name":"Clinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Iorio","sequence":"additional","affiliation":[{"name":"Dipartimento di Neuroscienze, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"},{"name":"Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Annicchiarico","sequence":"additional","affiliation":[{"name":"Regional Coordination of Rare Diseases (CoReMaR), Apulia Regional Agency for Health and Social Care (AReSS), Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \"Luigi Vanvitelli\", Monaldi Hospital, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Bonaria","family":"Uccheddu","sequence":"additional","affiliation":[{"name":"European Myasthenia Gravis Association (EuMGA), La Louviere, Belgium"},{"name":"AIM Associazione Italiana Miastenia ODV, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1934-5167","authenticated-orcid":false,"given":"Carlotta","family":"Galeone","sequence":"additional","affiliation":[{"name":"Bicocca Applied Statistics Center (B-ASC), Department of Economics, Management and Statistics, University of Milan-Bicocca, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mariani","sequence":"additional","affiliation":[{"name":"Bicocca Applied Statistics Center (B-ASC), Department of Economics, Management and Statistics, University of Milan-Bicocca, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,22]]},"reference":[{"key":"2025101810503282000_14.12.e086225.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00297-0"},{"key":"2025101810503282000_14.12.e086225.2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25122\/jml-2020-0145","article-title":"The epidemiology of myasthenia gravis","volume":"14","author":"Bubuioc","year":"2021","journal-title":"J Med Life"},{"key":"2025101810503282000_14.12.e086225.3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000328863","article-title":"Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years","volume":"36","author":"Pallaver","year":"2011","journal-title":"Neuroepidemiology"},{"key":"2025101810503282000_14.12.e086225.4","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"2025101810503282000_14.12.e086225.5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2025101810503282000_14.12.e086225.6","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00415-012-6478-6","article-title":"Characteristics of late-onset myasthenia gravis","volume":"259","author":"Zivkovi\u0107","year":"2012","journal-title":"J Neurol"},{"key":"2025101810503282000_14.12.e086225.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00145-3"},{"key":"2025101810503282000_14.12.e086225.8","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00415-010-5651-z","article-title":"Myasthenia gravis: a changing pattern of incidence","volume":"257","author":"Casetta","year":"2010","journal-title":"J Neurol"},{"key":"2025101810503282000_14.12.e086225.9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0404.1991.tb04654.x","article-title":"Comparative study on the prevalence of myasthenia gravis in the provinces of Bologna and Ferrara, Italy","volume":"83","author":"D\u2019Alessandro","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"2025101810503282000_14.12.e086225.10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0404.1989.tb03793.x","article-title":"Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986)","volume":"79","author":"Giagheddu","year":"1989","journal-title":"Acta Neurol Scand"},{"key":"2025101810503282000_14.12.e086225.11","unstructured":"Leoni S , Piluzza MG , Traccis S , et al . Incidence and prevalence trends of myasthenia Gravis in the Sardinian population, insular Italy. Neuroepidemiology 2014;43."},{"key":"2025101810503282000_14.12.e086225.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032487","article-title":"Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity","volume":"7","author":"Sardu","year":"2012","journal-title":"PLoS One"},{"key":"2025101810503282000_14.12.e086225.13","doi-asserted-by":"crossref","unstructured":"Schneider-Gold C , Hagenacker T , Melzer N , et al . Understanding the burden of refractory myasthenia gravis. Ther Adv Neurol Disord 2019;12. doi:10.1177\/1756286419832242","DOI":"10.1177\/1756286419832242"},{"key":"2025101810503282000_14.12.e086225.14","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617749134","article-title":"When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies","volume":"11","author":"Mantegazza","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"2025101810503282000_14.12.e086225.15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology (ECronicon)"},{"key":"2025101810503282000_14.12.e086225.16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology (ECronicon)"},{"key":"2025101810503282000_14.12.e086225.17","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10072-019-03746-1","article-title":"Italian recommendations for the diagnosis and treatment of myasthenia gravis","volume":"40","author":"Evoli","year":"2019","journal-title":"Neurol Sci"},{"key":"2025101810503282000_14.12.e086225.18","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1007\/s10072-024-07577-7","article-title":"Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion","volume":"45","author":"Mantegazza","year":"2024","journal-title":"Neurol Sci"},{"key":"2025101810503282000_14.12.e086225.19","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182111591","article-title":"Development of a Model Care Pathway for Myasthenia Gravis","volume":"18","author":"Payedimarri","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025101810503282000_14.12.e086225.20","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16180","article-title":"Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy","volume":"31","author":"Sacc\u00e0","year":"2024","journal-title":"Eur J Neurol"},{"key":"2025101810503282000_14.12.e086225.21","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1007\/s00415-021-10891-1","article-title":"Burden of disease in myasthenia gravis: taking the patient\u2019s perspective","volume":"269","author":"Lehnerer","year":"2022","journal-title":"J Neurol"},{"key":"2025101810503282000_14.12.e086225.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi","volume":"21","author":"Gattrell","year":"2024","journal-title":"PLoS Med"},{"key":"2025101810503282000_14.12.e086225.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.12.002"},{"key":"2025101810503282000_14.12.e086225.24","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v11.i4.116"},{"key":"2025101810503282000_14.12.e086225.25","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.00457","article-title":"Delphi Technique in Health Sciences: A Map","volume":"8","author":"Niederberger","year":"2020","journal-title":"Front Public Health"},{"key":"2025101810503282000_14.12.e086225.26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4172\/2167-1168.1000246","article-title":"Utilizing the Delphi Survey Approach: A Review","volume":"04","author":"Shariff","year":"2015","journal-title":"J Nurs Care"},{"key":"2025101810503282000_14.12.e086225.27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.techfore.2017.01.023","article-title":"Real-Time Delphi in practice \u2014 A comparative analysis of existing software-based tools","volume":"118","author":"Aengenheyster","year":"2017","journal-title":"Technol Forecast Soc Change"},{"key":"2025101810503282000_14.12.e086225.28","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"2025101810503282000_14.12.e086225.29","doi-asserted-by":"publisher","DOI":"10.1177\/0269216317690685"},{"key":"2025101810503282000_14.12.e086225.30","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-017-0676-3","article-title":"European Reference networks for rare diseases: what is the conceptual framework?","volume":"12","author":"H\u00e9on-Klin","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"2025101810503282000_14.12.e086225.31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.nmd.2020.08.355","article-title":"Mortality rates and causes of death in Swedish Myasthenia Gravis patients","volume":"30","author":"Westerberg","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"2025101810503282000_14.12.e086225.32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mus.24697","article-title":"Mortality in myasthenia gravis: A nationwide population\u2013based follow\u2010up study in Denmark","volume":"53","author":"Hansen","year":"2016","journal-title":"Muscle and Nerve"},{"key":"2025101810503282000_14.12.e086225.33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000506310","article-title":"Employment in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis","volume":"54","author":"Guastafierro","year":"2020","journal-title":"Neuroepidemiology"},{"key":"2025101810503282000_14.12.e086225.34","doi-asserted-by":"crossref","unstructured":"Gilhus NE , Verschuuren JJGM , Hovland SIB , et al . Myasthenia gravis: do not forget the patient perspective. Neuromuscul Disord 2021. doi:10.1016\/j.nmd.2021.07.396","DOI":"10.1016\/j.nmd.2021.07.396"},{"key":"2025101810503282000_14.12.e086225.35","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1007\/s12325-023-02604-z","article-title":"People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies","volume":"40","author":"Dewilde","year":"2023","journal-title":"Adv Ther"},{"key":"2025101810503282000_14.12.e086225.36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000336002","article-title":"Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy","volume":"38","author":"Montomoli","year":"2012","journal-title":"Neuroepidemiology"},{"key":"2025101810503282000_14.12.e086225.37","unstructured":"OrphaNet Report Series . Prevalence and incidence of rare diseases: Bibliographic data. INSERM 2022;1\u201395."},{"key":"2025101810503282000_14.12.e086225.38","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/acn3.52122","article-title":"The impact of diagnosis delay on European patients with generalised myasthenia gravis","volume":"11","author":"Cort\u00e9s-Vicente","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"2025101810503282000_14.12.e086225.39","unstructured":"OMAR . Miastenia, una malattia che non si vede. Progetto \u201cAlleanza Per La Miastenia Gravis, Available: https:\/\/www.osservatoriomalattierare.it\/documenti\/category\/7-documenti-vari?download=641:miastenia-una-malattia-che-non-si-vede-16-novembre-2021"},{"key":"2025101810503282000_14.12.e086225.40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22078-3","article-title":"Mental health in myasthenia gravis patients and its impact on caregiver burden","volume":"12","author":"Marbin","year":"2022","journal-title":"Sci Rep"},{"key":"2025101810503282000_14.12.e086225.41","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1816946"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-086225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:50:42Z","timestamp":1760809842000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-086225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,22]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/bmjopen-2024-086225"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-086225","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}